OTC Markets Group Welcomes Thiogenesis Therapeutics, Corp. to OTCQX
Portfolio Pulse from
Thiogenesis Therapeutics Corp. has upgraded to the OTCQX Best Market from the Pink market, as announced by OTC Markets Group. This move is expected to enhance the company's visibility and accessibility to investors.
February 12, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OTC Markets Group announced that Thiogenesis Therapeutics Corp. has upgraded to the OTCQX Best Market. This reflects positively on OTCM's role in facilitating market upgrades.
OTC Markets Group's announcement of Thiogenesis Therapeutics' upgrade to the OTCQX Best Market highlights its effectiveness in providing a platform for companies to enhance their market presence. This could positively impact OTCM's reputation and attract more companies to its markets.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 50